Nektar Therapeutics (NKTR) cash on hand

Cash · fiscal 2025
$245.75M

Nektar Therapeutics (NKTR) held cash of $245.75M at the end of fiscal 2025 (December 31, 2025). That is 3.7% lower than the $255.23M of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$245.75M
Change on fiscal 2024
−3.7%
Highest on record
$504.98Mfiscal 2022
Lowest on record
$245.75Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Nektar Therapeutics cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $504.98M in fiscal 2022 and the lowest $245.75M in fiscal 2025.

History · 4 fiscal years

Cash by fiscal year

Nektar Therapeutics cash on hand, year by year

Nektar Therapeutics (NKTR) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$245.75M 3.7% down
2024$255.23M 15.9% down
2023$303.62M 39.9% down
2022$504.98M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

More on NKTR

Nektar Therapeutics, figure by figure

Nektar Therapeutics (NKTR) overview: price, valuation and scorecard

Nektar Therapeutics cash on hand: questions and answers

How much cash does Nektar Therapeutics have?

Nektar Therapeutics (NKTR) held cash of $245.75M at the end of fiscal 2025 (December 31, 2025). That is 3.7% lower than the $255.23M of fiscal 2024.

What are the highest and lowest cash figures on record for Nektar Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $504.98M in fiscal 2022 and the lowest $245.75M in fiscal 2025.

How is Nektar Therapeutics's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Nektar Therapeutics it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Nektar Therapeutics (NKTR) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/NKTR/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.